- Home
- INO vs GDO Comparison
INO vs GDO Comparison
Compare INO & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- GDO
- Stock Information
- Founded
- INO 1979
- GDO 2009
- Country
- INO United States
- GDO United States
- Employees
- INO N/A
- GDO N/A
- Industry
- INO Medical/Dental Instruments
- GDO Finance Companies
- Sector
- INO Health Care
- GDO Finance
- Exchange
- INO Nasdaq
- GDO Nasdaq
- Market Cap
- INO 75.4M
- GDO 86.2M
- IPO Year
- INO 1998
- GDO N/A
- Fundamental
- Price
- INO $2.24
- GDO $11.37
- Analyst Decision
- INO Buy
- GDO
- Analyst Count
- INO 6
- GDO 0
- Target Price
- INO $17.00
- GDO N/A
- AVG Volume (30 Days)
- INO 739.9K
- GDO 39.4K
- Earning Date
- INO 03-05-2025
- GDO 01-01-0001
- Dividend Yield
- INO N/A
- GDO 9.81%
- EPS Growth
- INO N/A
- GDO N/A
- EPS
- INO N/A
- GDO N/A
- Revenue
- INO $203,413.00
- GDO N/A
- Revenue This Year
- INO N/A
- GDO N/A
- Revenue Next Year
- INO $1,970.14
- GDO N/A
- P/E Ratio
- INO N/A
- GDO N/A
- Revenue Growth
- INO N/A
- GDO N/A
- 52 Week Low
- INO $1.74
- GDO $11.21
- 52 Week High
- INO $14.75
- GDO $13.04
- Technical
- Relative Strength Index (RSI)
- INO 54.46
- GDO 50.77
- Support Level
- INO $1.82
- GDO $11.40
- Resistance Level
- INO $2.31
- GDO $11.52
- Average True Range (ATR)
- INO 0.14
- GDO 0.09
- MACD
- INO 0.05
- GDO 0.01
- Stochastic Oscillator
- INO 83.17
- GDO 51.52
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.